#AnestIwata

For the cumulative third quarter of FY March 2026, net sales were 39,488 million yen (YoY △1.3%), operating income was 3,796 million yen (YoY △18.1%), and net income attributable to owners of the parent was 3,376 million yen (YoY △5.6%).

3Q FY2026 sales were JPY 39,488 million (YoY -1.3%), operating income was JPY 3,796 million (YoY -18.1%), and the full-year earnings forecast remains unchanged.